540. Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine.
作者: David Fitz-Patrick.;Donald S McVinnie.;Lisa A Jackson.;Graham Crowther.;Anita Geevarughese.;Kevin D Cannon.;Lazaro M Garcia.;Yanely Pineiro Puebla.;Zhuobiao Yi.;Luke Cunliffe.;Alok Maniar.;Agnieszka M Zareba.;Claudia Ana Ianos.;Emily Gomme.;Kenneth Koury.;Pirada Suphaphiphat Allen.;Annaliesa S Anderson.;Alejandra Gurtman.;Kelly Lindert.; .
来源: N Engl J Med. 2025年393卷20期2001-2011页
Influenza remains a major health burden despite the use of licensed vaccines. Nucleoside-modified messenger RNA (modRNA) influenza vaccines have shown promising immunogenicity against influenza and an acceptable safety profile in a phase 1-2 trial.
|